Production of biologically active feline interferon beta in insect larvae using a recombinant baculovirus

ARREGUI, MARIANA BERNADETT; VILLAVERDE, MARCELA SOLANGE; MIRANDA, MARÍA VICTORIA; SMITH, IGNACIO; TARGOVNIK, ALEXANDRA MARISA; SMITH, IGNACIO; TARGOVNIK, ALEXANDRA MARISA; MC CALLUM, GREGORIO JUAN; WOLMAN, FEDERICO JAVIER; MC CALLUM, GREGORIO JUAN; WOLMAN, FEDERICO JAVIER; ARREGUI, MARIANA BERNADETT; VILLAVERDE, MARCELA SOLANGE; MIRANDA, MARÍA VICTORIA

3 Biotech

Springer

Lugar: Heidelberg; Año: 2018 vol. 8 p. 1 - 10

2190-572X

Feline interferon beta is a cytokine that belongs to the type I IFN family, with antitumor, antiviral and immunomodulatory functions. In this work, recombinant feline interferon beta (rFeIFNβ) was expressed in insect larvae that constitute important agronomic plagues. rFeIFNβ accumulated in the hemolymph of Spodoptera frugiperda larvae infected with recombinant baculovirus and was purified by Blue-Sepharose chromatography directly from larval homogenates on day 4 post-infection. rFeIFNβ was recovered after purification with a specific activity of 1 × 106 IU mg−1. By this method, we obtained 8.9 × 10 4 IU of purified rFeIFNβ per larva. The product was biologically active in vitro, with an antiviral activity of 9.5 × 104 IU mL−1,as well as a potent antitumor activity comparable to that of the commercial FeIFNω. The glycosylation of rFeIFNβ was confirmed by peptide-N-glycosidase F digestion. Our findings provide a cost-effective platform for large-scale rFeIFNβ production in laboratory research or veterinary medicine applications.